Goldenring JR - Search Results

1

Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor.

Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, Washington K, Goldenring JR, Coffey RJ. Burdick JS, et al. Among authors: goldenring jr. N Engl J Med. 2000 Dec 7;343(23):1697-701. doi: 10.1056/NEJM200012073432305. N Engl J Med. 2000. PMID: 11106719 Free article. No abstract available.

2

Roles for transforming growth factor-alpha in the stomach.

Coffey RJ, Romano M, Goldenring J. Coffey RJ, et al. J Clin Gastroenterol. 1995;21 Suppl 1:S36-9. J Clin Gastroenterol. 1995. PMID: 8774988 Review.

3

Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism.

Lewis JJ, Goldenring JR, Modlin IM, Coffey RJ. Lewis JJ, et al. Among authors: goldenring jr. Surgery. 1990 Aug;108(2):220-6; discussion 226-7. Surgery. 1990. PMID: 2382222

4

Overexpression of transforming growth factor-alpha alters differentiation of gastric cell lineages.

Goldenring JR, Ray GS, Soroka CJ, Smith J, Modlin IM, Meise KS, Coffey RJ Jr. Goldenring JR, et al. Dig Dis Sci. 1996 Apr;41(4):773-84. doi: 10.1007/BF02213134. Dig Dis Sci. 1996. PMID: 8674399

5

Transforming growth factor-alpha (TGF alpha) inhibition of parietal cell secretion: structural requirements for activity.

Goldenring JR, Tsunoda Y, Stoch SA, Coffey RJ, Modlin IM. Goldenring JR, et al. Regul Pept. 1993 Jan 22;43(1-2):37-47. doi: 10.1016/0167-0115(93)90405-w. Regul Pept. 1993. PMID: 8426908

6

Expression of trefoil peptides in the gastric mucosa of transgenic mice overexpressing transforming growth factor-alpha.

Goldenring JR, Poulsom R, Ray GS, Wright N, Meise KS, Coffey RJ Jr. Goldenring JR, et al. Growth Factors. 1996;13(1-2):111-9. doi: 10.3109/08977199609034571. Growth Factors. 1996. PMID: 8962716

7

Evidence for repatterning of the gastric fundic epithelium associated with Ménétrier's disease and TGFalpha overexpression.

Nomura S, Settle SH, Leys CM, Means AL, Peek RM Jr, Leach SD, Wright CV, Coffey RJ, Goldenring JR. Nomura S, et al. Among authors: goldenring jr. Gastroenterology. 2005 May;128(5):1292-305. doi: 10.1053/j.gastro.2005.03.019. Gastroenterology. 2005. PMID: 15887112

8

Efficacy of cetuximab in the treatment of Menetrier's disease.

Fiske WH, Tanksley J, Nam KT, Goldenring JR, Slebos RJ, Liebler DC, Abtahi AM, La Fleur B, Ayers GD, Lind CD, Washington MK, Coffey RJ. Fiske WH, et al. Among authors: goldenring jr. Sci Transl Med. 2009 Nov 25;1(8):8ra18. doi: 10.1126/scitranslmed.3000320. Sci Transl Med. 2009. PMID: 20368185 Free PMC article. Clinical Trial.

9

Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.

Nam KT, Varro A, Coffey RJ, Goldenring JR. Nam KT, et al. Among authors: goldenring jr. Gastroenterology. 2007 May;132(5):1804-19. doi: 10.1053/j.gastro.2007.03.040. Epub 2007 Mar 24. Gastroenterology. 2007. PMID: 17484876

10

Reversible drug-induced oxyntic atrophy in rats.

Goldenring JR, Ray GS, Coffey RJ, Meunier PC, Haley PJ, Barnes TB, Car BD. Goldenring JR, et al. Gastroenterology. 2000 Jun;118(6):1080-93. doi: 10.1016/s0016-5085(00)70361-1. Gastroenterology. 2000. PMID: 10833483

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters